Citation Impact
Citing Papers
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin
2004
Size regulation of von Willebrand factor–mediated platelet thrombi by ADAMTS13 in flowing blood
2005
Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring
2013 Standout
How I treat the acquired von Willebrand syndrome
2011
The endothelial glycocalyx: composition, functions, and visualization
2007 Standout
Sickle cell disease: old discoveries, new concepts, and future promise
2007
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Pathogenesis and Treatment of Sickle Cell Disease
1997
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin
2000
Endotoxin promotes adhesion of human erythrocytes to human vascular endothelial cells under conditions of flow
2000
Porcine platelets contain an increased quantity of ultra‐high molecular weight von Willebrand factor and numerous alpha‐granular tubular structures
1993
Apoptosis: controlled demolition at the cellular level
2007 Standout
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura
2001
Hyaluronan Anchoring and Regulation on the Surface of Vascular Endothelial Cells Is Mediated through the Functionally Active Form of CD44
2000
Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study
2010 StandoutNobel
Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome
2003
The Thrombospondins
2011 Standout
The Role of Stress Echocardiography in Valvular Heart Disease: A Current Appraisal
2017 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Solution Structure of Human von Willebrand Factor Studied Using Small Angle Neutron Scattering
2006
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
IgG4-Related Disease
2012 Standout
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management
2012
Platelets in atherothrombosis
2002
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Circadian control of the immune system
2013 Standout
Therapeutic apheresis in renal and metabolic diseases
2000
Neutrophil extracellular traps in immunity and disease
2017 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
What is Intervertebral Disc Degeneration, and What Causes It?
2006 Standout
Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation
2001
Platelets in inflammation and atherogenesis
2005 Standout
Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography
1998 Standout
Role of Thrombospondin-1 in Control of von Willebrand Factor Multimer Size in Mice
2004
Role of CD11/CD18 in shear rate-dependent leukocyte-endothelial cell interactions in cat mesenteric venules.
1991
Sickle-cell disease
2010 Standout
Identification of the haemoglobin scavenger receptor
2001 StandoutNature
Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients
2012
Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia
2005
IgG4-related disease
2014 Standout
IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
2009
Stroke risk in siblings with sickle cell anemia
2003
Von Willebrand Factor and Von Willebrand Factor-Cleaving Metalloprotease Activity in Escherichia coli O157:H7-Associated Hemolytic Uremic Syndrome
2001
Increased ADAMTS‐13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo
2006
Platelet Density Distribution in Essential Thrombocythemia
2010 StandoutNobel
Disseminated Intravascular Coagulation
1999 Standout
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
Glycoprotein Ibα and von Willebrand factor in primary platelet adhesion and thrombus formation: Lessons from mutant mice
2008
Acquired von Willebrand Syndrome in Aortic Stenosis
2003
Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets
2003
Rational design of antithrombotic peptides to target the von Willebrand Factor (vWf) - GPIb integrin interaction
2008 StandoutNobel
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Cleavage of ultra‐large von Willebrand factor by ADAMTS‐13 under flow conditions
2005
Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura
2001
Microvascular Blood Flow Is Altered in Patients with Sepsis
2002 Standout
Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology
1991
Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods
2003
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Syndromes of Thrombotic Microangiopathy
2014
von Willebrand factor–mediated platelet adhesion is critical for deep vein thrombosis in mouse models
2010
Anionic Polysaccharides Inhibit Adhesion of Sickle Erythrocytes to the Vascular Endothelium and Result in Improved Hemodynamic Behavior
1999
Thromboembolic Phenomena and the use of the Pig as an Appropriate Animal Model for Research on Cardiovascular Devices
1997 StandoutNobel
Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor
2009 Science
Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell–endothelium interactions induced by platelet-activating factor
2000
Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years
2000
Leukocyte-endothelial adhesion molecules
1994 Standout
Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8Y
2002
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor
2001
The distribution of erythrocyte phospholipids in hereditary spherocytosis demonstrates a minimal role for erythrocyte spectrin on phospholipid diffusion and asymmetry
1993 StandoutNobel
Introduction: anti-adhesion therapy in sickle cell disease
2000
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Assay of von Willebrand Factor (vWF)-cleaving Protease Based on Decreased Collagen Binding Affinity of Degraded vWF
1999
Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension
2000
Proteolysis of von Willebrand Factor and Shear Stress–Induced Platelet Aggregation in Patients With Aortic Valve Stenosis
2000
The ADAMTS metalloproteinases
2005
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
2016
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years
1997
Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin
2000
Adhesion of sickle red blood cells and damage to interleukin-1 beta stimulated endothelial cells under flow in vitro
1996
Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura
2004
Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity
2002
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Bleeding and Thrombosis in Patients With Continuous-Flow Ventricular Assist Devices
2012
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years
1997
Guidelines for the management of hemophilia
2012 Standout
Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia
1993
Works of HM Tsai being referenced
Shear stress enhances the proteolysis of von Willebrand factor in normal plasma
1994
Multimeric composition of endothelial cell-derived von Willebrand factor
1989
Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion
1993
Desmopressin induces adhesion of normal human erythrocytes to the endothelial surface of a perfused microvascular preparation
1990
Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion
1996
Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion
1993